Please login to the form below

Not currently logged in
Email:
Password:

Nuplazid

This page shows the latest Nuplazid news and features for those working in and with pharma, biotech and healthcare.

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug. Concludes Acadia Pharmaceuticals’ drug provides ‘ modest but meaningful’ benefits. ... Some atypical antipsychotic medicines are used to treat more advanced cases of PDP but -

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Srdjan Stankovic joins Acadia Pharmaceuticals Srdjan Stankovic joins Acadia Pharmaceuticals

    efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.”. ... I look forward to leading the team in advancing the promising development programmes with Nuplazid.".

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics